Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 7,080.00
+80.00 (1.14%)
Mar 12, 2026, 12:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 85.37 billion as of March 11, 2026. Its market cap has decreased by -36.64% in one year.
Market Cap
85.37B
Enterprise Value
63.68B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,080.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 85.37B, a decrease of -19.65%. That is a compound annual growth rate of -16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 85.37B | -25.91% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 221.03B |
| Vaxcell-Bio Therapeutics | 182.11B |
| Macrogen | 177.58B |
| iNtRON Biotechnology | 167.99B |
| MedPacto | 164.52B |
| ENCell | 164.47B |
| CG Invites | 104.19B |
| IMB Dx | 90.98B |